These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2869422

  • 1. The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia.
    Cross AJ, Crow TJ, Ferrier IN, Johnson JA.
    Neurobiol Aging; 1986; 7(1):3-7. PubMed ID: 2869422
    [Abstract] [Full Text] [Related]

  • 2. Serotonin receptor changes in dementia of the Alzheimer type.
    Cross AJ, Crow TJ, Ferrier IN, Johnson JA, Bloom SR, Corsellis JA.
    J Neurochem; 1984 Dec; 43(6):1574-81. PubMed ID: 6208336
    [Abstract] [Full Text] [Related]

  • 3. Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.
    Cross AJ, Crow TJ, Johnson JA, Perry EK, Perry RH, Blessed G, Tomlinson BE.
    J Neurol Sci; 1984 May; 64(2):109-17. PubMed ID: 6747659
    [Abstract] [Full Text] [Related]

  • 4. Changes in benzodiazepine receptors in Alzheimer-type dementia.
    Shimohama S, Taniguchi T, Fujiwara M, Kameyama M.
    Ann Neurol; 1988 Apr; 23(4):404-6. PubMed ID: 2837978
    [Abstract] [Full Text] [Related]

  • 5. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.
    Beal MF, Mazurek MF, Tran VT, Chattha G, Bird ED, Martin JB.
    Science; 1985 Jul 19; 229(4710):289-91. PubMed ID: 2861661
    [Abstract] [Full Text] [Related]

  • 6. Drug and transmitter receptors in human brain. Characterization and localization of serotonin, dopamine and adrenergic receptors.
    Maloteaux JM.
    Acta Neurol Belg; 1986 Jul 19; 86(2):61-129. PubMed ID: 2873704
    [Abstract] [Full Text] [Related]

  • 7. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.
    Crow TJ, Cross AJ, Cooper SJ, Deakin JF, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R.
    Neuropharmacology; 1984 Dec 19; 23(12B):1561-9. PubMed ID: 6084823
    [Abstract] [Full Text] [Related]

  • 8. High-molecular-weight forms of somatostatin are reduced in Alzheimer's disease and Down's syndrome.
    Pierotti AR, Harmar AJ, Simpson J, Yates CM.
    Neurosci Lett; 1986 Jan 16; 63(2):141-6. PubMed ID: 2869457
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia.
    Arai H, Moroji T, Kosaka K.
    Neurosci Lett; 1984 Nov 23; 52(1-2):73-8. PubMed ID: 6152043
    [Abstract] [Full Text] [Related]

  • 10. Regional distribution of neurotransmitter receptors in the visual structures of the rat brain.
    Schliebs R, Estrada E, Rothe T, Aurich M, Bigl V.
    Biomed Biochim Acta; 1984 Nov 23; 43(10):1119-25. PubMed ID: 6098272
    [Abstract] [Full Text] [Related]

  • 11. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S, Taniguchi T, Fujiwara M, Kameyama M.
    J Neurochem; 1986 Jan 23; 46(1):288-93. PubMed ID: 3940287
    [Abstract] [Full Text] [Related]

  • 12. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
    Bowen DM, Allen SJ, Benton JS, Goodhardt MJ, Haan EA, Palmer AM, Sims NR, Smith CC, Spillane JA, Esiri MM, Neary D, Snowdon JS, Wilcock GK, Davison AN.
    J Neurochem; 1983 Jul 23; 41(1):266-72. PubMed ID: 6306169
    [Abstract] [Full Text] [Related]

  • 13. Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.
    Jansen KL, Faull RL, Dragunow M, Synek BL.
    Neuroscience; 1990 Jul 23; 39(3):613-27. PubMed ID: 1965859
    [Abstract] [Full Text] [Related]

  • 14. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.
    Rossor MN, Emson PC, Mountjoy CQ, Roth M, Iversen LL.
    Neurosci Lett; 1980 Dec 23; 20(3):373-7. PubMed ID: 6108540
    [Abstract] [Full Text] [Related]

  • 15. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease.
    Lai MK, Tsang SW, Francis PT, Esiri MM, Keene J, Hope T, Chen CP.
    Brain Res; 2003 Jun 06; 974(1-2):82-7. PubMed ID: 12742626
    [Abstract] [Full Text] [Related]

  • 16. Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex.
    Quirion R, Richard J, Dam TV.
    Brain Res; 1985 May 06; 333(2):345-9. PubMed ID: 3995301
    [Abstract] [Full Text] [Related]

  • 17. Changes in beta-adrenergic receptor subtypes in Alzheimer-type dementia.
    Shimohama S, Taniguchi T, Fujiwara M, Kameyama M.
    J Neurochem; 1987 Apr 06; 48(4):1215-21. PubMed ID: 3029330
    [Abstract] [Full Text] [Related]

  • 18. Muscarinic, benzodiazepine, GABA, chloride channel and other binding sites in frontal cortex in hepatic coma in man.
    Lal S, Quirion R, Lafaille F, Nair NP, Loo P, Braunwalder A, Wood P, Williams M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Apr 06; 11(2-3):243-50. PubMed ID: 2442800
    [Abstract] [Full Text] [Related]

  • 19. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.
    Cheng AV, Ferrier IN, Morris CM, Jabeen S, Sahgal A, McKeith IG, Edwardson JA, Perry RH, Perry EK.
    J Neurol Sci; 1991 Nov 06; 106(1):50-5. PubMed ID: 1779239
    [Abstract] [Full Text] [Related]

  • 20. Biochemical characterization of alpha-adrenergic receptors in human brain and changes in Alzheimer-type dementia.
    Shimohama S, Taniguchi T, Fujiwara M, Kameyama M.
    J Neurochem; 1986 Oct 06; 47(4):1295-301. PubMed ID: 3018166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.